Protease-Activated Receptor 4: A Critical Participator in Inflammatory Response

Inflammation

Volumn 38, Issue 2, 2015, Pages 886-895

  Fu, Qiang ^a   Cheng, Jing ^a   Gao, Yebo ^b   Zhang, Yonglei ^a   Chen, Xiaobing ^a   Xie, Jianguo ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

coagulation; inflammation; mechanisms; protease activated receptor 4

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PEPTIDE HYDROLASE; PROTEASE-ACTIVATED RECEPTOR 4; THROMBIN RECEPTOR;

ANIMAL; BLOOD CLOTTING; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD COAGULATION; HUMANS; INFLAMMATION; PEPTIDE HYDROLASES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION;

EID: 84922342412     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9999-6     Document Type: Article

References (121)

1. Vu, T.-K.H., D.T. Hung, V.I. Wheaton, and S.R. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057–1068.
2. Hollenberg, M.D., M. Saifeddine, B. Al-Ani, and Y. Gui. 1999. Proteinase-activated receptor 4 (PAR4): Action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2. Canadian Journal of Physiology and Pharmacology 77: 458–464.
3. Coughlin, S.R. 2000. Thrombin signalling and protease-activated receptors. Nature 407: 258–264.
4. Steinhoff, M., J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T.A. Luger, and M.D. Hollenberg. 2005. Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response. Endocrine Reviews 26: 1–43.
5. Ramachandran, R., and M. Hollenberg. 2008. Proteinases and signalling: Pathophysiological and therapeutic implications via PARs and more. British Journal of Pharmacology 153: S263–S282.
6. Macfarlane, S.R., M.J. Seatter, T. Kanke, G.D. Hunter, and R. Plevin. 2001. Proteinase-activated receptors. Pharmacological Reviews 53: 245–282.
7. Ossovskaya, V.S., and N.W. Bunnett. 2004. Protease-activated receptors: Contribution to physiology and disease. Physiological Reviews 84: 579–621.
8. Kahn, M.L., Y.-W. Zheng, W. Huang, V. Bigornia, D. Zeng, S. Moff, R.V. Farese, C. Tam, and S.R. Coughlin. 1998. A dual thrombin receptor system for platelet activation. Nature 394: 690–694.
9. Kahn, M.L., M. Nakanishi-Matsui, M.J. Shapiro, H. Ishihara, and S.R. Coughlin. 1999. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. Journal of Clinical Investigation 103: 879–887.
10. Nakanishi-Matsui, M., Y.-W. Zheng, D.J. Sulciner, E.J. Weiss, M.J. Ludeman, and S.R. Coughlin. 2000. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609–613.
11. McLaughlin, J.N., M.M. Patterson, and A.B. Malik. 2007. Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proceedings of the National Academy of Sciences 104: 5662–5667.
12. Riewald, M., R.J. Petrovan, A. Donner, B.M. Mueller, and W. Ruf. 2002. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880–1882.
13. Riewald, M., V.V. Kravchenko, R.J. Petrovan, P.J. O’Brien, L.F. Brass, R.J. Ulevitch, and W. Ruf. 2001. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97: 3109–3116.
14. Boire, A., L. Covic, A. Agarwal, S. Jacques, S. Sherifi, and A. Kuliopulos. 2005. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120: 303–313.
15. Lourbakos, A., Y. Yuan, A.L. Jenkins, J. Travis, P. Andrade-Gordon, R. Santulli, J. Potempa, and R.N. Pike. 2001. Activation of protease-activated receptors by gingipains fromPorphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 97: 3790–3797.
16. Cocks, T.M., and J.D. Moffatt. 2000. Protease-activated receptors: Sentries for inflammation? Trends in Pharmacological Sciences 21: 103–108.
17. Sambrano, G.R., E.J. Weiss, Y.-W. Zheng, W. Huang, and S.R. Coughlin. 2001. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413: 74–78.
18. Asfaha, S., N. Cenac, S. Houle, C. Altier, M. Papez, C. Nguyen, M. Steinhoff, K. Chapman, G. Zamponi, and N. Vergnolle. 2007. Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulation. British Journal of Pharmacology 150: 176–185.
19. Vergnolle, N., C.K. Derian, M.R. D’Andrea, M. Steinhoff, and P. Andrade-Gordon. 2002. Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. The Journal of Immunology 169: 1467–1473.
20. McDougall, J.J., C. Zhang, L. Cellars, E. Joubert, C.M. Dixon, and N. Vergnolle. 2009. Triggering of proteinase‐activated receptor 4 leads to joint pain and inflammation in mice. Arthritis and Rheumatism 60: 728–737.
21. Kawabata, A., R. Kuroda, N. Kuroki, H. Nishikawa, and K. Kawai. 2000. Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease‐activated receptors (PARs): a novel role for PAR‐4 as opposed to PAR‐1. British Journal of Pharmacology 131: 578–584.
22. Bretschneider, E., R. Kaufmann, M. Braun, G. Nowak, E. Glusa, and K. Schrör. 2001. Evidence for functionally active protease‐activated receptor‐4 (PAR‐4) in human vascular smooth muscle cells. British Journal of Pharmacology 132: 1441–1446.
23. Kataoka, H., J.R. Hamilton, D.D. McKemy, E. Camerer, Y.-W. Zheng, A. Cheng, C. Griffin, and S.R. Coughlin. 2003. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102: 3224–3231.
24. Hollenberg, M.D., M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle. 2004. Proteinase‐activated receptor‐4: Evaluation of tethered ligand‐derived peptides as probes for receptor function and as inflammatory agonists in vivo. British Journal of Pharmacology 143: 443–454.
25. Houle, S., M.D. Papez, M. Ferazzini, M.D. Hollenberg, and N. Vergnolle. 2005. Neutrophils and the kallikrein–kinin system in proteinase‐activated receptor 4‐mediated inflammation in rodents. British Journal of Pharmacology 146: 670–678.
26. Russell, F.A., Veldhoen, V.E., Tchitchkan, D., and McDougall, J.J. 2009. Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism. Receptor.
27. Leger, A.J., S.L. Jacques, J. Badar, N.C. Kaneider, C.K. Derian, P. Andrade-Gordon, L. Covic, and A. Kuliopulos. 2006. Blocking the protease-activated receptor 1–4 heterodimer in platelet-mediated thrombosis. Circulation 113: 1244–1254.
28. Nieman, M.T. 2008. Protease-activated receptor 4 uses anionic residues to interact with α-thrombin in the absence or presence of protease-activated receptor 1†. Biochemistry 47: 13279–13286.
29. Holinstat, M., B. Voss, M.L. Bilodeau, J.N. McLaughlin, J. Cleator, and H.E. Hamm. 2006. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. Journal of Biological Chemistry 281: 26665–26674.
30. Voss, B., J.N. McLaughlin, M. Holinstat, R. Zent, and H.E. Hamm. 2007. PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis. Molecular Pharmacology 71: 1399–1406.
31. Knut, F., H. Linda, G. Peter, N. Martina, L.L. Tomas, and G. Magnus. 2011. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. Biochemical Journal 436: 469–480.
32. Arora, P., T.K. Ricks, and J. Trejo. 2007. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. Journal of Cell Science 120: 921–928.
33. Covic, L., A.L. Gresser, and A. Kuliopulos. 2000. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39: 5458–5467.
34. Faruqi, T.R., E.J. Weiss, M.J. Shapiro, W. Huang, and S.R. Coughlin. 2000. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides determinants of specificity and utility in assays of receptor function. Journal of Biological Chemistry 275: 19728–19734.
35. Hung, D.T., T. Vu, N.A. Nelken, and S.R. Coughlin. 1992. Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor. The Journal of Cell Biology 116: 827–832.
36. Paul, B.Z., J. Jin, and S.P. Kunapuli. 1999. Molecular mechanism of thromboxane A2-induced platelet aggregation ESSENTIAL ROLE FOR P2T AC and α2ARECEPTORS. Journal of Biological Chemistry 274: 29108–29114.
37. Kim, S., C. Foster, A. Lecchi, T.M. Quinton, D.M. Prosser, J. Jin, M. Cattaneo, and S.P. Kunapuli. 2002. Protease-activated receptors 1 and 4 do not stimulate Gi signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of Gisignaling. Blood 99: 3629–3636.
38. Kim, S., J. Jin, and S.P. Kunapuli. 2006. Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets. Blood 107: 947–954.
39. Jantzen, H.-M., D.S. Milstone, L. Gousset, P.B. Conley, and R.M. Mortensen. 2001. Impaired activation of murine platelets lacking Gαi2. Journal of Clinical Investigation 108: 477–483.
40. Weiss, E.J., J.R. Hamilton, K.E. Lease, and S.R. Coughlin. 2002. Protection against thrombosis in mice lacking PAR3. Blood 100: 3240–3244.
41. Mao, Y., J. Jin, J.L. Daniel, and S.P. Kunapuli. 2009. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets. Platelets 20: 191–198.
42. Arachiche, A., M. de la Fuente, and M.T. Nieman. 2013. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets. PloS One 8: e55740.
43. DeWire, S.M., S. Ahn, R.J. Lefkowitz, and S.K. Shenoy. 2007. β-arrestins and cell signaling. Annual Review of Physiology 69: 483–510.
44. Reiter, E., and R.J. Lefkowitz. 2006. GRKs and β-arrestins: Roles in receptor silencing, trafficking and signaling. Trends in Endocrinology and Metabolism 17: 159–165.
45. Luttrell, L., S. Ferguson, Y. Daaka, W. Miller, S. Maudsley, G. Della Rocca, F.-T. Lin, H. Kawakatsu, K. Owada, and D. Luttrell. 1999. β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283: 655–661.
46. Yang, M., R. He, J. Benovic, and R. Ye. 2009. beta-Arrestin1 interacts with the G-protein subunits beta1gamma2 and promotes beta1gamma2-dependent Akt signalling for NF-kappaB activation. Biochemical Journal 417: 287–296.
47. Lodeiro, M., M. Theodoropoulou, M. Pardo, F.F. Casanueva, and J.P. Camiña. 2009. c-Src regulates Akt signaling in response to ghrelin via β-arrestin signaling-independent and-dependent mechanisms. PLoS One 4: e4686.
48. Goel, R., P.J. Phillips-Mason, D.M. Raben, and J.J. Baldassare. 2002. α-Thrombin induces rapid and sustained Akt phosphorylation by β-arrestin1-dependent and-independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression. Journal of Biological Chemistry 277: 18640–18648.
49. Buchanan, F.G., D.L. Gorden, P. Matta, Q. Shi, L.M. Matrisian, and R.N. DuBois. 2006. Role of β-arrestin 1 in the metastatic progression of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 103: 1492–1497.
50. Álvarez, C.J., M. Lodeiro, M. Theodoropoulou, J.P. Camiña, F.F. Casanueva, and Y. Pazos. 2009. Obestatin stimulates Akt signalling in gastric cancer cells through β-arrestin-mediated epidermal growth factor receptor transactivation. Endocrine-Related Cancer 16: 599–611.
51. Goel, R., P.J. Phillips-Mason, A. Gardner, D.M. Raben, and J.J. Baldassare. 2004. α-Thrombin-mediated phosphatidylinositol 3-kinase activation through release of Gβγ dimers from Gαq and Gαi2. Journal of Biological Chemistry 279: 6701–6710.
52. Li, D., S. August, and D.S. Woulfe. 2008. GSK3β is a negative regulator of platelet function and thrombosis. Blood 111: 3522–3530.
53. Xiang, B., G. Zhang, J. Liu, A.J. Morris, S.S. Smyth, T.K. Gartner, and Z. Li. 2010. A Gi‐independent mechanism mediating Akt phosphorylation in platelets. Journal of Thrombosis and Haemostasis 8: 2032–2041.
54. Li, D., L. D’Angelo, M. Chavez, and D.S. Woulfe. 2011. Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. Journal of Biological Chemistry 286: 3805–3814.
55. Szotowski, B., S. Antoniak, W. Poller, H.-P. Schultheiss, and U. Rauch. 2005. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circulation Research 96: 1233–1239.
56. Sommeijer, D., H. Hansen, R. Van Oerle, K. Hamulyak, A. Van Zanten, E. Meesters, H. Spronk, and H. Ten Cate. 2006. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with type 2 diabetes. Journal of Thrombosis and Haemostasis 4: 574–580.
57. Bokarewa, M., J. Morrissey, and A. Tarkowski. 2002. Intra-articular tissue factor/factor VII complex induces chronic arthritis. Inflammation Research 51: 471–477.
58. Bokarewa, M.I., J.H. Morrissey, and A. Tarkowski. 2002. Tissue factor as a proinflammatory agent. Arthritis Research 4: 190–195.
59. Busso, N., V. Chobaz-Péclat, J. Hamilton, P. Spee, N. Wagtmann, and A. So. 2008. Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation. Arthritis Research and Therapy 10: R42.
60. Yang, Y.H., P. Hall, C.B. Little, A.J. Fosang, G. Milenkovski, L. Santos, J. Xue, P. Tipping, and E.F. Morand. 2005. Reduction of arthritis severity in protease‐activated receptor–deficient mice. Arthritis and Rheumatism 52: 1325–1332.
61. Cunningham, M.A., E. Rondeau, X. Chen, S.R. Coughlin, S.R. Holdsworth, and P.G. Tipping. 2000. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. The Journal of Experimental Medicine 191: 455–462.
62. Steranka, L.R., D.C. Manning, C.J. DeHaas, J.W. Ferkany, S.A. Borosky, J.R. Connor, R.J. Vavrek, J.M. Stewart, and S.H. Snyder. 1988. Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions. Proceedings of the National Academy of Sciences 85: 3245–3249.
63. Bignold, L., and A. Lykke. 1975. Increased vascular permeability induced in synovialis of the rat by histamine, serotonin and bradykinin. Experientia 31: 671–672.
64. Dick, W., D. Grennan, and I. Zeitlin. 1976. Studies on the relative effects of prostaglandins, bradykinin, 5‐hydroxytryptamine and histamine on the synovial microcirculation in dogs. British Journal of Pharmacology 56: 313–316.
65. Cruwys, S., B. Kidd, P. Mapp, D. Walsh, and D. Blake. 1992. The effects of calcitonin gene‐related peptide on formation of intra‐articular oedema by inflammatory mediators. British Journal of Pharmacology 107: 116–119.
66. Kanaka, R., H.-G. Schaible, and R. Schmidt. 1985. Activation of fine articular afferent units by bradykinin. Brain Research 327: 81–90.
67. Neugebauer, V., H.-G. Schaible, and R. Schmidt. 1989. Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflügers Archiv 415: 330–335.
68. Vergnolle, N., M.D. Hollenberg, K.A. Sharkey, and J.L. Wallace. 1999. Characterization of the inflammatory response to proteinase‐activated receptor‐2 (par2)‐activating peptides in the rat paw. British Journal of Pharmacology 127: 1083–1090.
69. Steinhoff, M., N. Vergnolle, S. Young, M. Tognetto, S. Amadesi, H. Ennes, M. Trevisani, M. Hollenberg, J. Wallace, and G. Caughey. 2000. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nature Medicine 6: 151–158.
70. de Garavilla, L., N. Vergnolle, S.H. Young, H. Ennes, M. Steinhoff, V.S. Ossovskaya, M.R. D’Andrea, E.A. Mayer, J.L. Wallace, and M.D. Hollenberg. 2001. Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanism. British Journal of Pharmacology 133: 975–987.
71. D’Andrea, M.R., M.R. Saban, N.-B. Nguyen, P. Andrade-Gordon, and R. Saban. 2003. Expression of protease-activated receptor-1,-2,-3, and-4 in control and experimentally inflamed mouse bladder. The American Journal of Pathology 162: 907–923.
72. Wang, Z., D. Chen, Z. Zhang, R. Zhang, S. An, and L. Yu. 2013. Protease‐activated receptor 4 activation increases the expression of calcitonin gene‐related peptide mRNA and protein in dorsal root ganglion neurons. Journal of Neuroscience Research 91: 1551–1562.
73. Vellani, V., A.M. Kinsey, M. Prandini, S.C. Hechtfischer, P. Reeh, P.C. Magherini, C. Giacomoni, and P.A. McNaughton. 2010. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones. Molecular Pain 6: 61.
74. Donnerer, J., and I. Liebmann. 2011. Phosphorylation of ERK1/2 in dorsal root ganglia following sequential mustard oil and thermal stimulation of the rat hind paw. Pharmacology 89: 7–12.
75. Brunet, A., D. Roux, P. Lenormand, S. Dowd, S. Keyse, and J. Pouysségur. 1999. Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry. The EMBO Journal 18: 664–674.
76. Hochholdinger, F., G. Baier, A. Nogalo, B. Bauer, H.H. Grunicke, and F. Überall. 1999. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells. Molecular and Cellular Biology 19: 8052–8065.
77. Lanigan, T.M., and A.F. Russo. 1997. Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. Journal of Biological Chemistry 272: 18316–18324.
78. Nakanishi, M., K. Hata, T. Nagayama, T. Sakurai, T. Nishisho, H. Wakabayashi, T. Hiraga, S. Ebisu, and T. Yoneda. 2010. Acid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: a potential mechanism of inflammatory pain. Molecular Biology of the Cell 21: 2568–2577.
79. Tajti, J., A. Kuris, L. Vécsei, C.-B. Xu, and L. Edvinsson. 2011. Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2. Cephalalgia 31: 95–105.
80. Hetman, M., and A. Gozdz. 2004. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. European Journal of Biochemistry 271: 2050–2055.
81. Chen, R., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Molecular and Cellular Biology 12: 915–927.
82. Ritchie, E., M. Saka, C. Mackenzie, R. Drummond, C. Wheeler‐Jones, T. Kanke, and R. Plevin. 2007. Cytokine upregulation of proteinase‐activated‐receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase β in human endothelial cells. British Journal of Pharmacology 150: 1044–1054.
83. Ma, C., K.A. Bower, G. Chen, X. Shi, Z.-J. Ke, and J. Luo. 2008. Interaction between ERK and GSK3β mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells. Journal of Biological Chemistry 283: 9248–9256.
84. De Sousa, L.P., B.S. Brasil, B.M. Silva, M.H. Freitas, S.V. Nogueira, P.C. Ferreira, E.G. Kroon, and C.A. Bonjardim. 2005. Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochemical and Biophysical Research Communications 329: 237–245.
85. Versteeg, H., K. Borensztajn, M. Kerver, W. Ruf, P. Reitsma, C. Spek, and M. Peppelenbosch. 2008. TF: FVIIa‐specific activation of CREB upregulates proapoptotic proteins via protease‐activated receptor‐2. Journal of Thrombosis and Haemostasis 6: 1550–1557.
86. Wang, H., S. Wen, N.W. Bunnett, R. Leduc, M.D. Hollenberg, and W.K. MacNaughton. 2008. Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through β-catenin and cyclic AMP-response element-binding protein. Journal of Biological Chemistry 283: 809–815.
87. Lei, L., X. Yuan, S. Wang, F. Zhang, Y. Han, Q. Ning, G. Luo, and S. Lu. 2012. Mitogen-activated protein kinase pathways are involved in the upregulation of calcitonin gene-related peptide of rat trigeminal ganglion after organ culture. Journal of Molecular Neuroscience 48: 53–65.
88. Ji, R.-R., H. Baba, G.J. Brenner, and C.J. Woolf. 1999. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nature Neuroscience 2: 1114–1119.
89. Zhu, W.-J., H. Yamanaka, K. Obata, Y. Dai, K. Kobayashi, T. Kozai, A. Tokunaga, and K. Noguchi. 2005. Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia. Brain Research 1041: 205–211.
90. Bulling, D.G., D. Kelly, S. Bond, D.S. McQueen, and J.R. Seckl. 2001. Adjuvant‐induced joint inflammation causes very rapid transcription of β‐preprotachykinin and α‐CGRP genes in innervating sensory ganglia. Journal of Neurochemistry 77: 372–382.
91. Ambalavanar, R., M. Moritani, A. Moutanni, P. Gangula, C. Yallampalli, and D. Dessem. 2006. Deep tissue inflammation upregulates neuropeptides and evokes nociceptive behaviors which are modulated by a neuropeptide antagonist. Pain 120: 53–68.
92. Xu, X., P. Wang, X. Zou, D. Li, L. Fang, and Q. Lin. 2009. Increases in transient receptor potential vanilloid‐1 mRNA and protein in primary afferent neurons stimulated by protein kinase C and their possible role in neurogenic inflammation. Journal of Neuroscience Research 87: 482–494.
93. Benemei, S., P. Nicoletti, J.G. Capone, and P. Geppetti. 2009. CGRP receptors in the control of pain and inflammation. Current Opinion in Pharmacology 9: 9–14.
94. Dattilio, A., and M.A. Vizzard. 2005. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. The Journal of Urology 173: 635–639.
95. Chen, D., Z. Wang, Z. Zhang, R. Zhang, and L. Yu. 2013. Capsaicin up-regulates protease-activated receptor-4 mRNA and protein in primary cultured dorsal root ganglion neurons. Cellular and Molecular Neurobiology 33: 337–346.
96. Asfaha, S., V. Brussee, K. Chapman, D.W. Zochodne, and N. Vergnolle. 2002. Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuli. British Journal of Pharmacology 135: 1101–1106.
97. Bar-Shavit, R., A. Kahn, G.D. Wilner, and J.W. Fenton. 1983. Monocyte chemotaxis: Stimulation by specific exosite region in thrombin. Science 220: 728–731.
98. Bar-Shavit, R., and G.D. Wilner. 1986. Biologic activities of nonenzymatic thrombin: Elucidation of a macrophage interactive domain. Seminars in Thrombosis and Hemostasis 12: 244–249.
99. Herbert, J., E. Dupuy, M. Laplace, J. Zini, S.R. Bar, and G. Tobelem. 1994. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochemical Journal 303: 227–231.
100. Kaplan, A.P., K. Joseph, and M. Silverberg. 2002. Pathways for bradykinin formation and inflammatory disease. Journal of Allergy and Clinical Immunology 109: 195–209.
101. Auge, C., D. Balz‐hara, M. Steinhoff, N. Vergnolle, and N. Cenac. 2009. Protease‐activated receptor‐4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterology and Motility 21: 1189–e1107.
102. Kawabata, A., R. Kuroda, H. Nishikawa, and K. Kawai. 1999. Modulation by protease‐activated receptors of the rat duodenal motility in vitro: Possible mechanisms underlying the evoked contraction and relaxation. British Journal of Pharmacology 128: 865–872.
103. Tognetto, M., M. Trevisani, B. Maggiore, G. Navarra, A. Turini, R. Guerrini, N.W. Bunnett, P. Geppetti, and S. Harrison. 2000. Evidence that PAR‐1 and PAR‐2 mediate prostanoid‐dependent contraction in isolated guinea‐pig gallbladder. British Journal of Pharmacology 131: 689–694.
104. Xu, W.-f., H. Andersen, T.E. Whitmore, S.R. Presnell, D.P. Yee, A. Ching, T. Gilbert, E.W. Davie, and D.C. Foster. 1998. Cloning and characterization of human protease-activated receptor 4. Proceedings of the National Academy of Sciences 95: 6642–6646.
105. Bradesi, S. 2009. PAR4: a new role in the modulation of visceral nociception. Neurogastroenterology and Motility 21: 1129–1132.
106. Mule, F., R. Pizzuti, A. Capparelli, and N. Vergnolle. 2004. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 53: 229–234.
107. Maggi, C.A. 1995. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progress in Neurobiology 45: 1–98.
108. Grady, E.F., P. Baluk, S. Böhm, P.D. Gamp, H. Wong, D.G. Payan, J. Ansel, A.L. Portbury, J.B. Furness, and D.M. McDonald. 1996. Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract. The Journal of Neuroscience 16: 6975–6986.
109. Serio, R., F. Mule, F. Bonvissuto, and A. Postorino. 1998. Tachykinins mediate noncholinergic excitatory neural responses in the circular muscle of rat proximal colon. Canadian Journal of Physiology and Pharmacology 76: 684–689.
110. Csuka, E., V.H. Hans, E. Ammann, O. Trentz, T. Kossmann, and M.C. Morganti-Kossmann. 2000. Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport 11: 2587–2590.
111. Popovich, P.G. 2000. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Progress in Brain Research 128: 43.
112. Stoll, G., S. Jander, and M. Schroeter. 1998. Inflammation and glial responses in ischemic brain lesions. Progress in Neurobiology 56: 149–171.
113. Benveniste, E.N. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. Journal of Molecular Medicine 75: 165–173.
114. McGeer, E.G., and P.L. McGeer. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Experimental Gerontology 33: 371–378.
115. Ryu, J., H. Pyo, I. Jou, and E. Joe. 2000. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-κB. Journal of Biological Chemistry 275: 29955–29959.
116. Suo, Z., M. Wu, B.A. Citron, C. Gao, and B.W. Festoff. 2003. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. Journal of Biological Chemistry 278: 31177–31183.
117. Möller, T., U.K. Hanisch, and B.R. Ransom. 2000. Thrombin‐induced activation of cultured rodent microglia. Journal of Neurochemistry 75: 1539–1547.
118. Suo, Z., M. Wu, S. Ameenuddin, H.E. Anderson, J.E. Zoloty, B.A. Citron, P. Andrade‐Gordon, and B.W. Festoff. 2002. Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activation. Journal of Neurochemistry 80: 655–666.
119. Hirano, K., N. Nomoto, M. Hirano, F. Momota, A. Hanada, and H. Kanaide. 2007. Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells. Journal of Pharmacology and Experimental Therapeutics 322: 668–677.
120. Steinberg, S.F. 2005. The cardiovascular actions of protease-activated receptors. Molecular Pharmacology 67: 2–11.
121. Sabri, A., J. Guo, H. Elouardighi, A.L. Darrow, P. Andrade-Gordon, and S.F. Steinberg. 2003. Mechanisms of Protease-activated Receptor-4 Actions in Cardiomyocytes ROLE OF Src TYROSINE KINASE. Journal of Biological Chemistry 278: 11714–11720.